Details

Autor(en) / Beteiligte

• López-Rodríguez, Larissa
• Svyryd, Yevgeniya
• Benítez-Alonso, Edmar O
• Rivero-García, Pamela
• Luna-Muñoz, Leonora
• Mutchinick, Osvaldo M

Titel

Severe Congenital Neutropenia Type 4: A Rare Disease Harboring a G6pc3 Gene Pathogenic Variant Particular to the Mexican Population

Ist Teil von

• Revista de investigacion clinica, 2022, Vol.74 (6), p.328-339

Ort / Verlag

Mexico: Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán

Erscheinungsjahr

2022

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Severe congenital neutropenia type 4 (SCN4) is a rare autosomal recessive granulopoiesis disorder caused by gene pathogenic variants. The estimated prevalence is 1/10,000,000 people. Over 90% of patients present a syndromic form with variable multisystemic involvement, including congenital heart defects, increased visibility of superficial veins (IVSV), inflammatory bowel disease, and congenital urogenital defects as prominent symptoms. The objective of the study was to study non-hematological phenotypic findings that suggest a clinical diagnosis of SCN4. We examined medical records of patients diagnosed with neutropenia from January 2000 to December 2020, selecting cases with non-hematologic manifestations for phenotypic description and gene sequencing. We found 11 cases with non-hematologic features: congenital heart defects in 8, IVSV in 6, inflammatory bowel disease in 4, urogenital defects in 4, and similar facial appearance. In addition, Sanger sequencing confirmed 3 homozygous cases for the c.210delC variant, a compound heterozygous harboring this variant, and a c.199_218+1 deletion. Our findings of the c.210delC variant in very close geographical settings, to date, have only been reported among Mexicans, and a mutual uncommon surname in two families strongly supports a founder effect for the variant in the studied population. Furthermore, the described non-hematologic symptoms in patients with severe primary neutropenia should be explored, confirming SCN4 by investigating gene mutations.